Login to Your Account

Financings Roundup

Tuesday, January 10, 2012
• Senesco Technologies Inc., of Bridgewater, N.J., entered into a securities purchase agreement to raise $2 million through the sale of 7.69 million shares of common stock. Outside investors also will receive 50 percent warrant coverage at an exercise price of $0.286 per share. Each unit was priced at 26 cents each. Net proceeds are expected to cover working capital and research and development as well as general corporate purposes. The company is developing SNS01-T in multiple myeloma and other B-cell cancers.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription